Healthcare Startup MUrgency Secures Investment From Ratan Tata

Ratan Tata has invested in San Francisco based medical emergency response company, MUrgency Inc., developing a global emergency network.

The company’s mobile app makes emergency response available with one tap on a mobile phone in under 9.0 minutes in urban areas.

MUrgency will use the proceeds of the funding to augment technology and scale operations besides leveraging Tata’s experience and network as a global business leader to develop the emergency response network globally through appropriate partnerships.

Ratan Tata has made more than 25 investments in startups in the last two years.

Healthcare startups that have benefitted from his investment include Lybrate, Swasth India and Invictus Oncology.

Founded in 2014 by Indian Social Entrepreneur Shaffi Mather in Silicon Valley and incubated out of Stanford ChangeLabs, Murgency recently received investment from Kris Gopalakrishnan and S. D. Shibulal led Axilor Ventures.

MUrgency launched their service in Punjab on 16 February, 2016 with a a responder network of 36 hospital emergency rooms, 40+ ambulances and 350+ medical professionals. MUrgency is slated to launch service in Amritsar and Jalandhar in the last week of May and cover entire state of Punjab by end June, 2016.

The company plans to make its services available across India by 2018 and around the world by 2020.

“Tata’s involvement is an affirmation of the importance of a reliable emergency medical response network for the world and of course India to save lives which are otherwise lost for want of timely medical attention. He clearly wanted us to launch and grow the network in India first before taking it overseas. Mr. Tata’s investment in MUrgency will help attract leading talent to the company and major partnerships beyond India,” said Shaffi Mather, Founder, MUrgency Inc.

 

 

Picture of Editor

Editor

You may also like

Get the latest

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Hot news

Travel

Lorem ipsum dolor sit amet consectetur adipiscing elit dolor

Most popular